0,951  0,004  Apoptosis agonist
0,921  0,005  Antiinflammatory
0,881  0,004  Caspase 9 stimulant
0,880  0,005  Antineoplastic (lung cancer)
0,848  0,010  Transcription factor NF kappa B inhibitor
0,831  0,004  Chemopreventive
0,826  0,004  Nitric oxide antagonist
0,810  0,004  Hepatic disorders treatment
0,811  0,008  Antineoplastic (breast cancer)
0,797  0,004  Caspase 3 stimulant
0,793  0,005  Antineoplastic (ovarian cancer)
0,760  0,004  Antineoplastic (pancreatic cancer)
0,752  0,005  5 Hydroxytryptamine release stimulant
0,752  0,005  Antineoplastic (melanoma)
0,744  0,003  Hepatoprotectant
0,746  0,006  Prostate cancer treatment
0,726  0,012  Antineoplastic (colorectal cancer)
0,722  0,011  Antileukemic
0,716  0,005  AR expression inhibitor
0,714  0,003  Antineoplastic (endocrine cancer)
0,708  0,013  Antineoplastic (colon cancer)
0,706  0,013  TNF expression inhibitor
0,698  0,014  Antidiabetic
0,698  0,014  Cyclophilin D inhibitor
0,675  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,659  0,009  Antineoplastic (cervical cancer)
0,651  0,003  ICAM1 expression inhibitor
0,649  0,004  Protein-tyrosine phosphatase inhibitor
0,648  0,011  Sensitization
0,638  0,002  AMP-activated protein kinase stimulant
0,639  0,006  Antineoplastic (glioma)
0,610  0,009  Apoptosis antagonist
0,615  0,015  Chemoprotective
0,588  0,003  Interferon gamma antagonist
0,594  0,012  Antioxidant
0,578  0,004  Phospholipase C inhibitor
0,574  0,010  Hypoglycemic
0,579  0,016  CYP2C19 substrate
0,564  0,011  Antineoplastic (multiple myeloma)
0,568  0,015  Cytotoxic
0,571  0,022  Cholesterol antagonist
0,550  0,004  Antiviral (Influenza A)
0,542  0,009  Vascular (periferal) disease treatment
0,537  0,004  Antiviral (Influenza)
0,541  0,009  Antineoplastic (glioblastoma multiforme)
0,545  0,014  NOS2 expression inhibitor
0,525  0,008  Antihypoxic
0,518  0,005  Insulin secretagoues
0,530  0,016  NOS3 expression inhibitor
0,523  0,015  Antiparasitic
0,506  0,005  Contraceptive
0,510  0,010  Antihelmintic
0,505  0,010  UGT2B4 substrate
0,503  0,009  Antineoplastic (liver cancer)
0,495  0,004  Antiviral (Hepatitis B)
0,498  0,008  P-glycoprotein inhibitor
0,490  0,013  Antihypertriglyceridemic
0,480  0,008  Transcription factor STAT3 inhibitor
0,471  0,006  Prostate disorders treatment
0,465  0,003  Contraceptive female
0,470  0,010  UGT1A4 substrate
0,465  0,009  Hair growth stimulant
0,473  0,021  Proliferative diseases treatment
0,477  0,025  Cardioprotectant
0,473  0,023  Antineoplastic (brain cancer)
0,453  0,007  Antiacne
0,473  0,030  Antihypercholesterolemic
0,451  0,008  Antiviral (Hepatitis)
0,450  0,010  Antiviral (Herpes)
0,449  0,009  Abortion inducer
0,440  0,002  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,456  0,019  Tumour necrosis factor alpha release inhibitor
0,463  0,026  Lipoprotein disorders treatment
0,453  0,020  Antipyretic
0,448  0,020  Hypoxia-inducible factor 1 alpha inhibitor
0,437  0,010  Prostatic (benign) hyperplasia treatment
0,465  0,047  CYP3A4 substrate
0,426  0,014  Transcription factor STAT inhibitor
0,414  0,004  Antiinfertility, female
0,444  0,038  Immunostimulant
0,418  0,013  Sodium/bile acid cotransporter inhibitor
0,426  0,022  Cardiodepressant
0,403  0,011  UGT2B7 substrate
0,391  0,005  Cholesterol synthesis inhibitor
0,396  0,015  Antiviral (HIV)
0,426  0,048  Vasodilator, peripheral
0,394  0,016  Antineoplastic (sarcoma)
0,412  0,046  Bone diseases treatment
0,418  0,056  Immunosuppressant
0,417  0,060  Antipruritic, allergic
0,386  0,031  Free radical scavenger
0,431  0,078  Alzheimer's disease treatment
0,358  0,013  Lipocortins synthesis antagonist
0,372  0,038  Antidiabetic (type 2)
0,356  0,024  Wound healing agent
0,363  0,032  Antineoplastic (renal cancer)
0,362  0,034  Antineoplastic (lymphoma)
0,351  0,026  UDP-glucuronosyltransferase substrate
0,362  0,040  Antineoplastic (non-small cell lung cancer)
0,334  0,015  Gastrin inhibitor
0,367  0,051  Antipsoriatic
0,354  0,044  Interleukin 2 agonist
0,319  0,012  Antiviral (Hepatitis C)
0,339  0,036  Angiogenesis stimulant
0,329  0,026  UGT1A1 substrate
0,343  0,040  Cardiovascular analeptic
0,316  0,015  UGT2B15 substrate
0,302  0,013  Acute respiratory distress syndrome (ARDS) treatment
0,305  0,017  Antihelmintic (Nematodes)
0,292  0,004  Transcription factor NF kappa B stimulant
0,340  0,053  Antiosteoporotic
0,324  0,038  UGT1A6 substrate
0,349  0,065  Antithrombotic
0,321  0,037  Antiulcerative
0,294  0,017  Insulin sensitizer
0,270  0,009  UGT2B10 substrate
0,307  0,047  Hypolipemic
0,274  0,014  UGT2B9 substrate
0,317  0,065  Analeptic
0,276  0,026  Antineoplastic (squamous cell carcinoma)
0,259  0,009  Androgen antagonist
0,268  0,022  Protein kinase stimulant
0,282  0,039  Platelet adhesion inhibitor
0,251  0,009  Cyclooxygenase 3 inhibitor
0,262  0,021  Interleukin 6 antagonist
0,296  0,055  Antiprotozoal (Leishmania)
0,244  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,268  0,029  Neurotrophic factor enhancer
0,343  0,106  Antibacterial
0,273  0,041  Anesthetic general
0,256  0,026  Lipid peroxidase inhibitor
0,304  0,074  Respiratory analeptic
0,234  0,004  Phosphorylase inhibitor
0,243  0,014  Antihemorrhagic
0,253  0,025  Liver fibrosis treatment
0,304  0,078  Antifungal
0,236  0,014  Farnesoid X receptor antagonist
0,226  0,006  Inducible nitric-oxide synthase inhibitor
0,246  0,027  Skin whitener
0,284  0,067  UGT1A9 substrate
0,221  0,007  Adenylate cyclase stimulant
0,226  0,014  Arachidonic acid antagonist
0,244  0,032  Antineoplastic (carcinoma)
0,244  0,037  Antipruritic, non-allergic
0,275  0,069  Teratogen
0,286  0,081  Metabolic disease treatment
0,226  0,021  DNA polymerase I inhibitor
0,233  0,034  Diuretic
0,252  0,054  Carcinogenic
0,215  0,021  Antitussive
0,212  0,018  Expectorant
0,195  0,005  Anabolic
0,276  0,087  CTGF expression inhibitor
0,297  0,109  CYP2C9 substrate
0,184  0,004  Aldosterone antagonist
0,195  0,018  Choleretic
0,181  0,009  CDC25A inhibitor
0,243  0,071  Antineoplastic (lymphocytic leukemia)
0,214  0,043  LDLR expression enhancer
0,177  0,007  UGT2B11 substrate
0,210  0,041  Amylase inhibitor
0,215  0,047  Diabetic nephropathy treatment
0,203  0,035  Antirickettsial
0,173  0,010  Estrogen agonist
0,237  0,077  Embryotoxic
0,200  0,041  Melanin inhibitor
0,162  0,004  Na+ K+ transporting ATPase inhibitor
0,163  0,005  Glycine receptor antagonist
0,161  0,004  RNA-directed RNA polymerase stimulant
0,181  0,025  Microtubule formation inhibitor
0,234  0,079  Vasodilator
0,157  0,003  Heme oxygenase stimulant
0,163  0,010  CC chemokine 6 receptor antagonist
0,193  0,042  Anesthetic
0,188  0,037  Antinephritic
0,165  0,014  ABCA1 expression enhancer
0,154  0,007  Androgen agonist
0,198  0,052  UGT1A3 substrate
0,153  0,010  Lanosterol 14 alpha demethylase inhibitor
0,184  0,042  Antidiabetic (type 1)
0,214  0,076  Antiparkinsonian, rigidity relieving
0,160  0,025  HDL-cholesterol increasing
0,141  0,007  5-Alpha-reductase inhibitor
0,274  0,143  Atherosclerosis treatment
0,163  0,033  Growth stimulant
0,139  0,010  Bile acid receptor antagonist
0,269  0,140  Antiobesity
0,144  0,016  Contraceptive male
0,150  0,028  Sulfotransferase substrate
0,160  0,042  Antihyperlipoproteinemic
0,148  0,031  Antineoplastic antibiotic
0,182  0,067  Muscle relaxant
0,129  0,016  Aromatase inhibitor
0,233  0,125  GST M1-1 substrate
0,142  0,034  Anticataract
0,120  0,014  Postmenopausal disorders treatment
0,118  0,013  Glycine receptor agonist
0,126  0,026  SULT1E1 substrate
0,129  0,028  Actinic keratosis treatment
0,104  0,004  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,150  0,053  Pregnane X receptor agonist
0,211  0,115  Radioprotector
0,134  0,038  Protease inhibitor
0,110  0,014  Anticholelithogenic
0,224  0,130  FMO3 substrate
0,099  0,005  Lipocortins synthesis agonist
0,101  0,008  SULT2A1 substrate
0,136  0,044  Alcohol dehydrogenase substrate
0,129  0,040  Estrogen antagonist
0,147  0,059  Psychosexual dysfunction treatment
0,095  0,007  Postcoital contraceptive
0,246  0,158  Histamine release inhibitor
0,133  0,046  SULT1A1 substrate
0,163  0,077  Growth hormone agonist
0,203  0,118  Interleukin agonist
0,094  0,009  Diacylglycerol O-acyltransferase inhibitor
0,110  0,025  3C-Like protease (SARS coronavirus) inhibitor
0,148  0,066  Skeletal muscle relaxant
0,232  0,152  Vasodilator, coronary
0,122  0,043  Antiprotozoal (Toxoplasma)
0,111  0,033  Ornithine decarboxylase inhibitor
0,118  0,042  Potassium channel (Ca-activated) activator
0,170  0,095  Non-steroidal antiinflammatory agent
0,088  0,013  Estrogen receptor beta agonist
0,103  0,029  Keratolytic
0,082  0,010  Acetyl-CoA transferase 2 inhibitor
0,074  0,004  Tubulin agonist
0,119  0,049  UGT2B1 substrate
0,179  0,109  Antineoplastic enhancer
0,080  0,012  Estrogen receptor alpha agonist
0,072  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,085  0,018  Nitric oxide donor
0,069  0,004  Cholesterol ester transfer protein antagonist
0,069  0,007  Microtubule stabilization
0,067  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,074  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,129  0,072  Liver cirrhosis treatment
0,138  0,080  Ca2+-transporting ATPase inhibitor
0,168  0,111  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,127  0,071  Retinoprotector
0,064  0,007  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,069  0,013  Adenylate cyclase 1 inhibitor
0,107  0,051  Estrogen receptor beta antagonist
0,244  0,191  Alpha-glucosidase inhibitor
0,076  0,024  Transcription factor AP-1 inhibitor
0,154  0,103  Toxic, respiratory center
0,066  0,018  Anesthetic inhalation
0,169  0,121  Antialcoholic
0,181  0,133  DNA damaging
0,085  0,039  SULT1A2 substrate
0,057  0,011  Farnesoid X receptor agonist
0,194  0,149  CYP2D6 substrate
0,052  0,007  Estrone sulfatase inhibitor
0,190  0,146  Renal disease treatment
0,103  0,059  Chronic obstructive bronchitis treatment
0,079  0,036  Potassium channel large-conductance Ca-activated activator
0,056  0,014  Parathyroid hormone antagonist
0,100  0,059  Nitric-oxide synthase inhibitor
0,045  0,004  Hedgehog signaling activator
0,064  0,026  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,109  0,072  Interleukin 1b antagonist
0,188  0,151  Antineoplastic (bladder cancer)
0,072  0,035  CDC25B inhibitor
0,036  0,002  Telomerase stimulant
0,207  0,175  Antineoplastic (osteosarcoma)
0,110  0,078  Beta amyloid protein antagonist
0,044  0,017  p53 inhibitor
0,129  0,103  Phospholipase A2 inhibitor
0,209  0,183  FMO1 substrate
0,032  0,006  Corticosteroid-like
0,052  0,027  Cholesterol esterase inhibitor
0,039  0,016  HMG CoA reductase inhibitor
0,046  0,023  Liver X receptor alpha agonist
0,029  0,007  Progesterone agonist
0,055  0,034  Acetyl-CoA transferase inhibitor
0,083  0,062  mTOR complex 2 inhibitor
0,102  0,082  Adenylate cyclase inhibitor
0,093  0,074  Glutathione S-transferase substrate
0,038  0,020  Glucocorticoid antagonist
0,031  0,014  1,3-Beta-glucan synthase inhibitor
0,095  0,079  Beta glucuronidase inhibitor
0,212  0,196  Calcium channel activator
0,216  0,202  Antiprotozoal
0,020  0,006  Vitamin D receptor agonist
0,068  0,056  Lipase inhibitor
0,018  0,008  Glucocorticoid agonist
0,060  0,050  Hyperparathyroidism treatment
0,022  0,012  5-Alpha-reductase 2 inhibitor
0,066  0,056  Andropause treatment
0,023  0,014  Vitamin D receptor antagonist
0,070  0,061  Topoisomerase II alpha inhibitor
0,187  0,179  5 Hydroxytryptamine uptake stimulant
0,041  0,033  Liver X receptor agonist
0,010  0,002  Transcortin receptor antagonist
0,041  0,036  Heme oxygenase inhibitor
0,026  0,021  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,022  0,017  Retinoic acid gamma receptor agonist
0,047  0,042  CD45 antagonist
0,022  0,017  Retinoid X gamma receptor agonist
0,084  0,079  Glutamate release inhibitor
0,017  0,012  5-Alpha-reductase 1 inhibitor
0,102  0,099  Alpha-N-acetylglucosaminidase inhibitor
0,026  0,023  Retinoid X gamma receptor antagonist
0,078  0,076  Estrogen-related receptor beta agonist
0,018  0,018  Retinoic acid alpha receptor antagonist

